INS and type 2 diabetes mellitus: The insulin regimen distribution in LHLH’s discharge pharmacotherapy is more consistent with the recognized status of insulin treatment at discharge for T2DM as the addition of basal insulin being the most frequent and effective modification of treatment [16] and premix insulin formula an non-inferior choice to BBI [26].